Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04106440 · ClinicalTrials.gov registry record · NA

Pilot Study of Connected Diabetes Technology

A NA study of Diabetes Mellitus, Type 1, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
41
Enrollment target
1
Study location

NCT04106440 is a NA study of Diabetes Mellitus, Type 1 that has completed, run by University of California, Davis. The registered enrollment target is 41 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04106440, a NA study of Diabetes Mellitus, Type 1, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target
1
Study location

Study Summary

To test the hypothesis that remote sharing of health data - including measured blood glucose values as well as patient-reported carbohydrate counts and insulin doses - with the UC Davis Pediatric Diabetes team via connected health applications is feasible for pediatric patients with newly diagnosed type 1 diabetes.

Conditions Studied

Interventions

  • BEHAVIORAL Application Use

Study Locations (1)

California

  • University of California-Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2019-10-18
Est. Completion 2021-02-19
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04106440

The ClinicalTrials.gov registry entry for NCT04106440 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (97% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Application Use is the first listed.

NCT04106440 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04106440 about?

NCT04106440 is a clinical study titled "Pilot Study of Connected Diabetes Technology". To test the hypothesis that remote sharing of health data - including measured blood glucose values as well as patient-reported carbohydrate counts and insulin doses - with the UC Davis Pediatric Diabetes team via connected health applications is feasible for pediatric patients with newly diagnosed ...

What is the current status of trial NCT04106440?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-10-18. Estimated completion is 2021-02-19.

What conditions does trial NCT04106440 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.

What interventions are being tested in trial NCT04106440?

The interventions under investigation include: Application Use (BEHAVIORAL).

Who is sponsoring clinical trial NCT04106440?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04106440 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 1

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.